Access Bio has ranked among the top searched stocks on 8 days within the past month.


As of 12:30 PM on the 7th, Access Bio is trading at 26,700 KRW, down 6.32% from the previous day. This represents a 20.3% decrease compared to September 7. Access Bio is known as a specialized manufacturer of in vitro diagnostic products, including malaria diagnostic kits.

Over the past 5 days, individual investors have net purchased 216,335 shares, while foreign investors and institutions have net sold 190,313 shares and 60 shares, respectively.


On October 6, Access Bio became a market topic with news of an "↑ partnership for COVID-19 kit sales with an Australian diagnostic company."



※Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automatic article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing